Regencell Bioscience Holdings Ltd RGC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 09/17/21 EDT
20.03quote price arrow down-2.12 (-9.57%)
Volume
95,180
52 week range
6.00 - 59.00
Loading...
  • Open22.15
  • Day High22.70
  • Day Low20.02
  • Prev Close22.15
  • 52 Week High59.00
  • 52 Week High Date08/25/21
  • 52 Week Low6.00
  • 52 Week Low Date08/20/21

Key Stats

  • Market Cap259.79M
  • Shares Out12.97M
  • 10 Day Average Volume0.19M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open22.15
  • Day High22.70
  • Day Low20.02
  • Prev Close22.15
  • 52 Week High59.00
  • 52 Week High Date08/25/21
  • 52 Week Low6.00
  • 52 Week Low Date08/20/21
  • Market Cap259.79M
  • Shares Out12.97M
  • 10 Day Average Volume0.19M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.06
  • P/E (TTM)-311.51
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-859,960.00
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-118.70%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Regencell Bioscience Holdings Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
Address
11/F First Commercial Building
33-35 Leighton Roa
999077
Hong Kong